Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cilostazol induction of migraine aura
NCT02253004Phase 1Completed
- Sponsor
- Herlev Hospital
- Start
- Sep 2014
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial comparing Cilostazol with Placebo (2 arms). Primary endpoint: Aura Induction at 24 hours. Started Sep 2014; status: completed.
02
Drugs
cilostazol
Beyond the preview
Go deeper on NCT02253004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02253004.